Meeting
2022 ASCO Genitourinary Cancers Symposium
Genomic instability is enriched in localized prostate cancers from men of African ancestry.
Authors
Jones T. Nauseef
New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY
Jones T. Nauseef , Yajas Shah , Alon Shaiber , Joel Rosiene , David Wilkes , Michael Sigouros , Jyothi Manohar , Panagiotis J. Vlachostergios , Brian D. Robinson , Olivier Elemento , David M. Nanus , Juan Miguel Mosquera , Marcin Imielinski
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 270)
DOI
10.1200/JCO.2022.40.6_suppl.270
Abstract #
270
Poster Bd #
M2
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
The molecular hallmarks and clinical consequences of tumor hypoxia in prostate cancer.
First Author: Bhandari Vinayak
Poster
2018 Genitourinary Cancers Symposium
Genomic and phenotypic evidence for prostate cancer osteomimicry in circulating tumor cells from men with metastatic castration resistant prostate cancer (mCRPC) treated with radium-223.
First Author: Andrew J. Armstrong
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of a prostate cancer gastrointestinal transcriptional phenotype as found in clinical mCRPC samples with response to AR-targeted therapy.
First Author: Aishwarya Subramanian
Poster
2023 ASCO Genitourinary Cancers Symposium
Prospective validation of single nucleotide polymorphisms as predictors of gastrointestinal, genitourinary, and sexual toxicities following radiation therapy for prostate cancer.
First Author: Sophia C. Kamran